Based on the content, the domain is Clinical Infectious Diseases and Medical Epidemiology. I will adopt the persona of a Senior Consulting Infectious Disease Physician and Medical Editor, focusing on precise clinical relevance, epidemiological trends, and evidence-based treatment protocols.
Group Recommendation for Review
This content is best reviewed by Clinical Infectious Disease Specialists, Public Health Epidemiologists, and Medical Editors specializing in primary care/hospital medicine reporting. The host provides rapid-fire summaries of recent literature, touching on virology, bacteriology, public health policy critique, and antibiotic stewardship.
Abstract
This is a review of recent infectious disease literature from late December 2015, presented as the first "puscast" of 2016 by Dr. Mark Chryslup, an Infectious Disease physician. The discussion synthesizes findings across several microbiological and clinical domains, interspersed with strong commentary on public health relevance and resource allocation.
Key topics covered include: differential seroprevalence of Cytomegalovirus (CMV) among African-Americans compared to Caucasians, significant complications of Ebola virus (rhabdomyolysis), severe presentations of Chikungunya (acute nasal necrosis), the lack of benefit from increased oseltamivir dosing for influenza, and a highly critical report detailing the importation of rabies-positive animals into the US via falsified documentation. Epidemiological connections are drawn between Herpes Zoster (VZV) and increased risk of stroke, and the dramatic reduction in invasive Group A Streptococcus infections following VZV vaccine implementation. Treatment efficacy reviews focus on Chlamydia trachomatis (Doxycycline vs. Azithromycin in an incarcerated population) and changing epidemiology of Haemophilus ducreyi (shifting from STD to chronic pediatric ulcer). Finally, several waterborne outbreaks (Kingella, Legionella, Pseudomonas) are noted, alongside a discussion on appropriate fracture wound irrigation techniques (low-pressure saline favored over soap/high-pressure) and the clinical risks associated with mismanaging reported $\beta$-lactam allergies.
Synopsis of Literature Review: Infectious Disease Highlights (Early 2016)
00:00:05 Preamble & Disclosure: Introduction by Dr. Mark Chryslup, ID physician, noting this is the first podcast of 2016 covering late December 2015 literature. Explicitly states no conflicts of interest, having abstained from pharmaceutical sponsorship for over 30 years.
00:01:04 Congenital CMV Epidemiology: A study showed African-Americans have approximately double the rate of CMV seropositivity compared to Caucasians, concentrated in childbearing years, explaining higher congenital CMV disease rates. The underlying reason for this disparity remains an open research question.
Ebola Virus: Associated with severe rhabdomyolysis (frequently CK > 5,000), potentially contributing to observed kidney failure.
Chikungunya: Three adult cases reported in Venezuela presented with severe, multiorgan failure including acute nasal necrosis (AHAN).
00:03:01 Influenza Treatment: Double-dose oseltamivir provided no incremental benefit over standard dosing for influenza but increased adverse effects (nausea/vomiting).
00:03:22 Public Health Critique (Rabies): Strong condemnation of the importation of dogs/cats from Cairo with falsified rabies vaccination certificates, framing it as a severe misallocation of resources amid human suffering.
00:04:41 Zoster and Thrombosis: A study linked Herpes Zoster (shingles) with a short-term increased risk of stroke, emphasizing that prevention of VZV (via vaccination) may prevent associated vascular events. Suggestion that elderly patients might require a VZV booster approximately 10 years post-initial vaccination.
00:05:49 VZV and Strep Synergy: Routine VZV vaccination is associated with a 70% reduction in varicella-associated invasive Group A Streptococcus infections (e.g., necrotizing fasciitis). The speaker posits vaccination will likely also prevent the associated strokes.
00:06:34Chlamydia trachomatis Treatment: In an incarcerated population with directly observed therapy (DOT), Azithromycin (1g single dose) yielded a 97% cure rate versus 100% for Doxycycline (course therapy). Doxycycline efficacy in non-DOT settings is questioned.
00:07:20Haemophilus ducreyi (Shankroid): The epidemiology is shifting globally from primarily an STD to a common cause of chronic skin ulcers in children in the developing world.
00:08:02 Brucellosis Follow-Up: A local case of Brucella infection in a Polynesian patient was genetically traced to South Pacific strains, suggesting a remote infection acquisition (Tonga, four years prior) rather than recent local pig slaughter, despite the speaker expressing initial skepticism regarding the incubation period.
Kingella meningoseptica: 22-month outbreak in an English hospital traced to the water supply, affecting 30 patients.
Legionella: Outbreak associated with a hotel fountain.
Aeromonas: Recurrent infections in an elderly man traced to unfiltered well water, reinforcing the need to question patient water sources.
00:11:25 Organic Turkey Reservoir:Streptococcus galactolyticus subspecies galactolyticus was identified as potentially harbored by organic turkeys, serving as a potential reservoir for human infection.
00:12:06 Fracture Wound Irrigation: A randomized trial demonstrated that irrigation pressure (low, medium, or high) made no difference in outcomes for fracture wounds, but the use of soap resulted in more reoperations compared to saline. Saline irrigation at low pressure is endorsed as adequate.
00:13:29 $\beta$-Lactam Allergy Management: Review of data showing that patients receiving non-$\beta$-lactams for acute infections (often Gram-negative) due to perceived allergies had worse clinical outcomes. The actual rate of hypersensitivity reaction was low (2.9%), and only history of true anaphylaxis was significantly associated with repeat reaction. The speaker advocates for using $\beta$-lactams unless the allergy history is severe (e.g., death).
00:15:09 Doxycycline Substitution: Minocycline appears clinically equivalent to doxycycline for treating skin/soft tissue infections, CAP in healthy hosts, and certain Rickettsial illnesses, with the added benefit of treating acne.
00:16:40 Conclusion: The speaker concludes the rapid review, noting New Year's Day plans, and directs listeners to resources at edgedock.com.